(Reuters) - Teva Pharmaceuticals Industries Ltd said on Tuesday Yitzhak Peterburg, who previously served as the company’s chairman and interim chief executive, resigned from its board, effective immediately.

The debt-laden Israeli drugmaker has witnessed a series of changes in recent months after CEO Kare Schultz, who joined Teva on Nov. 1, ousted top division heads and rolled out a plan to streamline operations.